GT719 Injection for Moderate to Severe Refractory Autoimmune Disease

NCT07132112 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Auto Immune Disease

Interventions

BIOLOGICAL: GT719 Injection

Sponsor

Grit Biotechnology

Collaborators

[object Object]